Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: Clinical significance

International Journal of Cancer

Volumn 126, Issue 8, 2010, Pages 1828-1837

  Iwatsuki, Masaaki ^a,b   Mimori, Koshi ^b   Lshii, Hideshi ^b   Yokobori, Takehiko ^b   Takatsuno, Yasushi ^b   Sato, Tetsuya ^b   Toh, Hiroyuki ^b   Onoyama, Ichiro ^c   Nakayama, Keiichi I ^c   Baba, Hideo ^a   Mori, Masaki ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

C Myc; CGH array; Colorectal cancer; Cyclin E; FBXW7

Indexed keywords

CELL CYCLE PROTEIN; COMPLEMENTARY DNA; CYCLIN E; FBXW7 PROTEIN; MESSENGER RNA; MYC PROTEIN; UNCLASSIFIED DRUG; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; MYC PROTEIN, HUMAN; TUMOR MARKER; UBIQUITIN PROTEIN LIGASE;

AGED; ARTICLE; CANCER CELL CULTURE; CELL CYCLE REGULATION; CELL PROLIFERATION; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE COURSE; DNA FLANKING REGION; FEMALE; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LASER MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; ONCOGENE C MYC; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CYCLE; COLORECTAL TUMOR; DNA MICROARRAY; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; LASER; METABOLISM; MICRODISSECTION; MIDDLE AGED; RNA INTERFERENCE;

AGED; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; CYCLIN E; F-BOX PROTEINS; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LASERS; MALE; MICRODISSECTION; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 77949900799     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24879     Document Type: Article

References (24)

1. Bashir T, Pagano M. Aberrant ubiquitinmediated proteolysis of cell cycle regulatory proteins and oncogenesis. Adv Cancer Res 2003; 88: 101-144 (Pubitemid 36343280)
2. Akhoondi S, Sum D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D, Marth C, Mueller-Holzner E, Corcoran M, et al. FBX.W7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 2007; 67: 9006-9012 (Pubitemid 47535882)
3. Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI, Brown K, Bryson S, Balmain A. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 2004; 432: 775-779 (Pubitemid 39656299)
4. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8: 83-93. (Pubitemid 351161321)
5. Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M. Significance of skp2 expression in primary breast cancer. Clin Cancer Res 2006; 12: 1215-1220 (Pubitemid 43342511)
6. Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6: 369-381
7. Onoyama I, Tsunematsu R, Matsumoto A, Kimura T, de Alboran IM, Nakayama K, Nakayama KI. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 2007; 204: 2875-2888 (Pubitemid 350179557)
8. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res 2005; 11: 2889-2893 (Pubitemid 40525189)
9. Nishida K, Mine S, Utsunomiya T, Inoue H, Okamoto M, Udagawa H, Hanai T, Mori M. Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: a study combined with a laser microdissection and a cDNA microarray. Cancer Res 2005; 65: 401-409
10. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002; 32 (Suppl): 496-501.
11. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001; 29: 365-371 (Pubitemid 34326681)
12. Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 2007; 23: 657-663 (Pubitemid 46554715)
13. UtsunomiyaT,HaraY,KataokaA,MoritaM,ArakawaH,MoriM,NishimuraS. Cystatin-likemetastasis- associatedproteinmRNAexpressioninhumancolorectalcancerisassociatedwithbothliv ermetastasisandpatientsurvival.ClinCancerRes2002;8:2591-2594(Pubitemid34856345)
14. Utsunomiya T, Okamoto M, Hashimoto M, Yoshinaga K, Shiraishi T, Tanaka F, Mimori K, Inoue H, Watanabe G, Barnard GF, Mori M. A gene-expression signature can quantify the degree of hepatic fibrosis in the rat. J Hepatol 2004; 41: 399-406. (Pubitemid 39158749)
15. Lassmann S, Weis R, Makowiec F, Roth J, Danciu M, Hopt U, Werner M. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med 2007; 85: 293-304. (Pubitemid 46295243)
16. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, Liu H, Krier C, Stengel RF, Barany F, Gerald WL, Paty PB, et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 2006; 66: 2129-2137 (Pubitemid 43294922)
17. Sterian A, Kan T, Berki AT, Mori Y, Olaru A, Schulmann K, Sato F, Wang S, Paun B, Cai K, Hamilton JP, Abraham JM, et al. Mutational and LOH analyses of the chromosome 4q region in esophageal adenocarcinoma. Oncology 2006; 70: 168-172 (Pubitemid 44154689)
18. Takada H, Imoto I, Tsuda H, Sonoda I, Ichikura T, Mochizuki H, Okanoue T, Inazawa J. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci 2005; 96: 100-110 (Pubitemid 40425385)
19. Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, Lengauer C. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004; 428: 77-81. (Pubitemid 38332360)
20. Kemp Z, Rowan A, Chambers W, Wortham N, Halford S, Sieber O, Mortensen N, von Herbay A, Gunther T, Ilyas M, Tomlinson I. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability. Cancer Res 2005; 65: 11361-11366 (Pubitemid 41821693)
21. Welcker M, Singer J, Loeb KR, Grim J, Bloecher A, Gurien-West M, Clurman BE, Roberts JM. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell 2003; 12: 381-392 (Pubitemid 37238925)
22. Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000; 16: 653-699 (Pubitemid 32037520)
23. Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005; 24: 2776-2786
24. Gu Z, Mitsui H, Inomata K, Honda M, Endo C, Sakurada A, Sato M, Okada Y, Kondo T, Horii A. The methylation status of FBXW7 beta-form correlates with histological subtype in human thymoma. Biochem Biophys Res Commun 2008; 377: 685-688